Quintana, Francisco

Vice-President

11 Settembre 2018
1608 Views
Francisco J. Quintana, PhD
Professor of Neurology
Ann Romney Center for Neurologic Diseases
Brigham and Women’s Hospital
Harvard Medical School
Associate Member,
The Broad Institute of Harvard and MIT

Francisco J. Quintana, PhD is an Associate Professor of Neurology at the Center for Neurologic Diseases, at Brigham and Women’s Hospital, Harvard Medical School, and an Associate Member at the Broad Institute of Harvard and MIT.

 

Dr. Quintana, a graduate of the University of Buenos Aires (1999, Argentina), obtained his PhD in immunology at the Weizmann Institute of Science (2004, Israel).  He received postdoctoral training at the Weizmann Institute of Science and at Harvard Medical School.  In 2009, Dr. Quintana joined the faculty of Harvard Medical School.

Dr. Quintana’s research investigates signaling pathways that control the immune response and neurodegeneration, with the ultimate goal of identifying novel therapeutic targets and biomarkers for immune-mediated disorders.  Dr. Quintana has published over 150 peer reviewed articles and book chapters.  Dr. Quintana’s work identified an important role for the transcription factor AHR in the control of inflammation driven by adaptive and innate immune cells. His work has also identified important mechanisms that control neurodegeneration driven by CNS resident cells. In addition, Dr. Quintana’s research has resulted in multiple patents which have been the foundation of three companies: ImmunArray Ltd, Alma Bio Therapeutics and AnTolRx Inc.

Dr. Quintana is the recipient of the Lady Anne Chain Prize for Academic Excellence and Scientific Achievements, the Junior Investigator Award from the National Multiple Sclerosis Society, the Pathway to Independence Award of the National Institute of Allergy and Infectious Diseases, the Award for Outstanding Research Achievement form Nature Biotechnology, the Tecan Award for Innovation, the Harry Weaver Award from the National Multiple Sclerosis Society, the Mentor Award from Harvard Medical School, the Milestones in Multiple Sclerosis Research Award from the National Multiple Sclerosis Society and the AAI-BD Biosciences Investigator Award.

You may be interested

28th Annual Meeting of the European Charcot Foundation
News
43 views
News
43 views

28th Annual Meeting of the European Charcot Foundation

stine - 27 Luglio 2020

28th Annual Meeting of the European Charcot Foundation

ISNI – Nice 2021
Next congresses
12323 views
Next congresses
12323 views

ISNI – Nice 2021

edgardo - 23 Giugno 2020

15th International Congress of Neuroimmunology
3rd Global Schools of Neuroimmunology Pre-Course
November 8-12, 2021

APSNI – Sydney 2021
APSNI
11750 views
APSNI
11750 views

APSNI – Sydney 2021

stine - 23 Giugno 2020

3rd Asia-Pacific School of Neuroimmunology - APSNI
2021